The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Development of anti-TNF therapy for rheumatoid arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationInfliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Self-citationBeutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
Self-citationHuman tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationTransgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Davis, D., MACFARLANE, J. D., Antoni, C., Leeb, B. F., Elliott, M. J., Woody, J. N., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9<1552::aid-art5>3.0.co;2-w · Cited by 1,627
Self-citationMoreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Rheumatoid Arthritis: Pathophysiology and Implications for Therapy
Epstein, F. H., & Harris, E. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221805 · Cited by 1,551
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
Mease, P. J., Goffe, B. S., Metz, J., VanderStoep, A., Finck, B., & Burge, D. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02530-7 · Cited by 1,446
Vascular Endothelial Growth Factor
Ferrara, N. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179663 · Cited by 1,283
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Self-citationLee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,247
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
Lovell, D. J., Giannini, E. H., Reiff, A., Cawkwell, G. D., Silverman, E. D., Nocton, J. J., Stein, L. D., Gedalia, A., Ilowite, N. T., Wallace, C. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421103 · Cited by 1,246
INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Self-citationTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Self-citationCOLEY, W. B. (1991) · PubMed · Cited by 965
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J., Daddona, P., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90106-l · Cited by 703
Expression of human immune interferon cDNA in E. coli and monkey cells
Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., et al. (1982) · Nature · doi:10.1038/295503a0 · Cited by 689
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., et al. (1984) · Nature · doi:10.1038/312721a0 · Cited by 640
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
Self-citationDesigning CD4 immunoadhesins for AIDS therapy
Capon, D. J., Chamow, S. M., Mordenti, J., Marsters, S. A., Gregory, T., Mitsuya, H., Byrn, R. A., Lucas, C., Wurm, F. M., Groopman, J. E., et al. (1989) · Nature · doi:10.1038/337525a0 · Cited by 615
Chu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
Self-citationKoch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., & Ferrara, N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4149 · Cited by 575
Saxne, T., Palladino, M. A., Heinegãrd, D., Talal, N., & Wollheim, F. A. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310816 · Cited by 566
Brandt, J., Haibel, H., Cornely, D., Golder, W., Gonzalez, J., Reddig, J., Thriene, W., Sieper, J., & Braun, J. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200006)43:6<1346::aid-anr18>3.0.co;2-e · Cited by 485
Synthesis in E. coli of a polypeptide with human leukocyte interferon activity
Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ecsödi, J., Boll, W., Cantell, K., & Weissmann, C. (1980) · Nature · doi:10.1038/284316a0 · Cited by 481
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
Deswal, A., Bozkurt, B., Seta, Y., Parilti-Eiswirth, S., Hayes, F. A., Blosch, C., & Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.99.25.3224 · Cited by 393
The Mechanism of Immunological Paralysis
Dresser, D. W., & Mitchison, N. A. (1968) · Advances in Immunology · doi:10.1016/s0065-2776(08)60466-6 · Cited by 392
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Buchan, G. S., Barrett, K., Turner, M., Chantry, D., Maini, R. N., & Feldmann, M. (1988) · PubMed Central · Cited by 332
Self-citationPeppel, K., Crawford, D., & Beutler, B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1483 · Cited by 321
Type II Collagen Autoimmunity in Animals and Provocations Leading to Arthritis
Holmdahl, R., Andersson, M., Goldschmidt, T. J., Gustafsson, K. E., Jansson, L., & Mo, J. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00817.x · Cited by 307
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Self-citationButler, D., Maini, R. N., Feldmann, M., & Brennan, F. M. (1995) · PubMed · Cited by 288
Self-citationPaulus, H. E., Egger, M. J., Ward, J. R., & James Williams, H. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330403 · Cited by 285
Ballara, S., Taylor, P. C., Reusch, P., Marm�, D., Feldmann, M., Maini, R. N., & Paleolog, E. M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<2055::aid-art355>3.0.co;2-2 · Cited by 257
Self-citationThe nucleotide sequence of human fibroblast interferon cDNA
Taniguchi, T., Ohno, S., Fujii-Kuriyama, Y., & Muramatsu, M. (1980) · Gene · doi:10.1016/0378-1119(80)90138-9 · Cited by 254
The Classic: The Treatment of Malignant Tumors by Repeated Inoculations of Erysipelas
COLEY, W. B. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199101000-00002 · Cited by 254
Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117394 · Cited by 243
Self-citationPaleolog, E. M., Hunt, M., Elliott, M. J., Feldmann, M., Maini, R. N., & Woody, J. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390703 · Cited by 240
Self-citationDi Giovine, F. S., Malawista, S. E., Nuki, G., & Duff, G. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3213 · Cited by 232
Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., & Lesslauer, W. (1992) · PubMed Central · Cited by 232
Anti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 230
Self-citationMoreland, L. W., Margolies, G., Heck, L. W., Saway, A., Blosch, C. D., Hanna, R. K., & Koopman, W. J. (1996) · PubMed · Cited by 215
Choy, E. H. S. (2002) · Rheumatology · doi:10.1093/rheumatology/41.10.1133 · Cited by 213
Alvaro-Gracia, J. M., Zvaifler, N. J., Brown, C. B., Kaushansky, K., & Firestein, G. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3365 · Cited by 204
Cellular Sites of Immunologic Unresponsiveness
Chiller, J. M., Habicht, G. S., & Weigle, W. O. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.65.3.551 · Cited by 200
Manipulation Of T-Cell Responses With Monoclonal Antibodies
Waldmann, H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.407 · Cited by 194
Saklatvala, J., Sarsfield, S. J., & Townsend, Y. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.4.1208 · Cited by 193
Lacraz, S., Isler, P., Vey, E., Welgus, H. G., & Dayer, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31750-7 · Cited by 177
Cytokine production in the rheumatoid joint: implications for treatment.
Feldmann, M., Brennan, F. M., Chantry, D., Haworth, C., Turner, M., Abney, E. R., Buchan, G. S., Barrett, K., Barkley, D., & Chu, A. C. (1990) · PubMed · Cited by 146
Self-citationI. The Treatment of Malignant Tumors by Repeated Inoculations of Erysipelas
COLEV, W. B. (1893) · Annals of Surgery · doi:10.1097/00000658-189307000-00009 · Cited by 134
Adverse reactions to TNF-α inhibitors in rheumatoid arthritis
Day, R. O. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07718-8 · Cited by 131
Preliminary results of early clinical trials with the fully human anti-TNFα monoclonal antibody D2E7
Kempeni, J. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i70 · Cited by 131
Isler, P., Vey, E., Zhang, J., & Dayer, J. (1993) · PubMed · Cited by 118
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients
Cody, J. D., Daly, C. D., Campbell, M., Khan, I. H., Rabindranath, K. S., Vale, L. D., Wallace, S. A., MacLeod, A. M., Grant, A., Pennington, S., et al. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003266.pub2 · Cited by 111
Edwards, C. K. (1999) · Annals of the Rheumatic Diseases · doi:10.1136/ard.58.2008.i73 · Cited by 90
Oudin, J., & MICHEL, M. (1963) · PubMed · Cited by 87
Davis, D., Charles, P. J., Potter, A. R., Feldmann, M., Maini, R. N., & Elliott, M. J. (1997) · Rheumatology · doi:10.1093/rheumatology/36.9.950 · Cited by 86
Self-citationKruys, V., Kemmer, K. A., Shakhov, A., Jongeneel, C. V., & Beutler, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.673 · Cited by 70
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Bahn, R. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905750 · Cited by 1,552
Metadata
- Authors
- Feldmann, M.
- Venue
- Nature Reviews Immunology
- Published
- 2002-05
- Volume
- 2
- Issue
- 5
- Pages
- 364-371
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1523595999
- Cited by
- 673
- References
- 74
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.